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Myringosclerosis is a scar of the tympanic membrane 
lamina propria, resulting from trauma or inflammation, 
characterized by proliferation of collagen, hyalinization, 
calcium and phosphate deposits and cartilaginous or osseous 
metaplasia of the middle ear mucosa, a sequence that is 
similar to that taking place in other types of pathologic 
calcification, common in chronic renal failure (CRF). Aim: To 
verify the influence of chronic renal failure on the prevalence 
of myringosclerosis. Method: The otoscopic examination was 
done in 341 chronic renal failure patients and in 356 normal 
control individuals. The frequency of positive otoscopies 
was compared between the two groups, based on individual 
variables and those pertaining to CRF. Results: 11.7% of the 
patients had a positive otoscopy in the CRF group, compared 
to 5.1% in the control group. There was no statistical diference 
in the frequency of myringosclerosis acording to gender, 
ethnic group, time of dialysis or serum minerals. The groups 
had a wide age range. Conclusion: Although the findings of 
this study suggest a higher ocurrence of myringosclerosis in 
patients with renal disease, they do not provide a basis for 
stating that there is any relation between renal failure and 
tympanic alterations.
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INTRODUCTION
Tympanosclerosis is histologically characterized by 
hyaline degeneration of the middle ear mucosa, followed 
by calcium and phosphorus deposits in the submucosa,1,2 
that becomes hardened, even bone-like.
This condition may occur in the tympanic membra-
ne, where it is named myringosclerosis,3 easily identified 
during otoscopy; it may also occur in other middle ear 
sites, with a preference for the attic.
Other forms of pathological calcification found in 
different bodily tissues are similar to tympanosclerosis in 
that they involve matrix vesicles, fibroblasts, macrophages 
and various enzymes.4-13 These forms of calcifications are 
the result of calcium and phosphorus dysmetabolism, and 
are found in other systemic conditions, including chronic 
renal failure (CRF). Based on this, our study aimed to 
find a possible cause-effect relation between CRF and 
tympanosclerosis.
OBJECTIVE
The aim was to assess the influence of CRF on the 
occurrence of tympanosclerosis.
SERIES AND METHOD
This paper is a cross-sectional epidemiological trial 
with a study group (group A) and a control group (group 
B). Group A was composed of 341 CRF patients in he-
modialysis therapy, and group B was composed of 356 
caretakers of patients from the outpatient and infirmary 
sectors of the Otorhinolaryngology Unit with no otological 
complaints and no kidney disease. The 341 study group 
patients were recruited from three separate hemodialysis 
units in the city of Recife.
Age ranged from 10 to 88 years; the mean age in 
group A was 46.5 years (SD ± 14.84), and the mean age 
in group B was 39.9 years (SD ± 14.39). There were 422 
females and 275 males in the total sample, of which 101 
were white, 101 were black and 495 were brown.
Data collection was done between March and June 
2002. Subjects underwent a questionnaire (Annex A) and 
an otoscopic exam.
The closed-question questionnaire was applied in 
an interview and contained identification data (sex, age, 
color) and the otological morbidity history (history of 
otalgia and/or otorrhea).
Otoscopy was done with a Welch Allyn model 
71000-C 3.5 V rechargeable battery (72300) otoscope, 
always by two examiners who remained the same for all 
of the subjects.
Upon inclusion, serum calcium, phosphorus and 
parathormone (PTH) were investigated in 225 patients 
from one of the hemodialysis clinics.
Otoscopy was positive if a typical plaque was seen 
on the tympanic membrane. In elderly patients, naturally 
occurring (for this age) diffuse opacification of the tympa-
nic membrane was not considered myringosclerosis.
Normal serum calcium was within 8.4 and 10.2 mg/
dl. Normal serum phosphorus was between 2.7 and 4.5mg/
dl. Normal PTH levels were between 14 and 106 pg/ml.
A positive history of otitis was defined as past epi-
sodes of otalgia or otorrhea.
The duration of dialysis was counted from the first 
recorded session in the patient file until the day in which 
otoscopy was done.
The Epi-Info 6.0 StatCalc module formula for calcu-
lating “n” was used at a 5% significance level and an 80% 
power. Data analysis was done using descriptive statistics, 
using central trend and dispersion measurements, and 
analytical statistics, using the Yates corrected chi-square 
test (x2) (p<0.05).
RESULTS
The prevalence of myringosclerosis in 697 patients 
was 8.3% (n = 58). The prevalence in group B was 5.1% 
(n = 18); the prevalence in CRF patients was 11.7% (n = 
40). The latter group had a 2.5 times chance of having a 
positive otoscopy compared to the control group (CI = 
1.21 - 1.77; PR = 1.46; p = 0.002), as shown in Table 1.
There were other eventual otoscopic findings, such 
as tympanic perforation, in six group A subjects and ex-
ternal otitis in two group A subjects.
Table 1. Frequency of myringosclerosis in group A and B subjects.
 myringosclerosis  no myringosclerosis 
TOTAL
n% n%
GROUP A 40 11,7 301 88,3 341 100
GROUP B 18 5,1 338 94,9 356 100
TOTAL 58 8,3 639 91,7 697 100
PR = 1.46; CI = 1.21- 1.77; p = 0.002
 
Myringosclerosis and a history of otitis
Of 58 subjects with myringosclerosis, 10 (17.2%) had 
a history that suggested middle ear inflammatory disease, 
while 114 (17.8%) of 639 subjects with no myringosclerosis 
reported prior episode(s) of otologic disease, which was 
not statistically significant (p = 0.94). Groups A and B had 
a similar otological history of disease, which was positive 
in 64 (18.7%) of the CRF patients and in 60 (16.9%) of 
the control group subjects (PR = 1.07; CI = 0.88 - 1.29; 
p = 0.57), and which was not statistically significant, as 
shown in Table 2.
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On the other hand, if we exclude from both groups 
those subjects that had a history of otitis (64 in group A and 
60 in group B), we are left with 573 subjects, 277 in group 
A and 296 in group B. Among the 277 group A patients, 
34 (12.3%) had myringosclerosis; among the 296 control 
group subjects, 14 (4.7%) had myringosclerosis (Table 
3). These findings are even more statistically significant 
compared to the original sample that included all of the 
patients (PR = 1.53; CI = 1.25 - 1,88; p = 0.001).
Myringosclerosis and color
In the full sample there were 101 white subjects 
(14.5%), 101 black subjects (14.5%) and 495 brown sub-
jects (71%).
Table 5 shows that in group A these numbers were 
41 white (12.0%), 60 black (17.6%) and 240 brown (70.4%); 
in group B these numbers were 60 white (16.9%), 41 black 
(11.5%) and 255 brown (71.6%). The groups were, there-
fore, similar in skin color (x2= 7.28; p = 0.02).
Among the subjects with positive otoscopies for 
myringosclerosis, 11 (19.0%) were white, 10 (17.2%) 
were black and 37 (63.8%) were brown. In subjects with 
no myringosclerosis 90 (14.1%) were white, 91 (14.2%) 
were black and 458 (71.7%) were brown (x2 = 1.67; p 
= 0.43).
Table 2. Frequency distribution of past otitis in group A and B sub-
jects.
 past otitis  no past otitis  TOTAL
n% n% n%
GROUP A 64 18,7 277 81,3 341 100
GROUP B 60 16,9  296 83,1 356 100
TOTAL 124 17,8  573 82,2 697 100
PR = 1.07; CI = 0.88 - 1.29; p = 0.57
Table 3. Frequency of myringosclerosis in groups A and B with no 
history of otitis.
 myringosclerosis 
no 
myringosclerosis TOTAL
n% n%
GROUP A 34 12,3 243 87,7 277 100
GROUP B 14 4,7 282 95,3 296 100
TOTAL 48 8,4 525 91,6 573 100
PR = 1.53; CI = 1.25 - 1.88; p = 0.001
 
Myringosclerosis and gender
There were 422 (60.5%) female subjects and 275 
(39.5%) male subjects. Among the subjects that presented 
myringosclerosis, 35 (60.3%) were female and 23 (39.7%) 
were male (p = 0.91).
In the CRF group there were 153 (44.9%) males and 
188 (55.1%) females. In the control group, there were 87 
(24.5%) males and 269 (75.5%) females (x2 = 67.41; p < 
0.001), as shown in Table 4.
 
Table 4. Distribution of subjects according to sex in groups A e B.
 male  female TOTAL
n% n% n%
GROUP A 153 44,9 188 55,1 341 100
GROUP B  87 24,5 269 75,5 356 100
TOTAL  240 34,4  457 65,6 697 100
x2 = 67.41; p < 0.001
Table 5. Distribution of subjects according to color in groups A e B.
 white  black  brown  TOTAL
n% n% n% n%
GROUP A 41 12,0 60 17,6 240 70,4 341 100
GROUP B 60 16,9  41 11,5  255 71,6 356 100
TOTAL  101 14,5  101 14,5  495 71,0 697 100
x2 = 7,28 p = 0,02
 
Myringosclerosis and age
The sample was grouped into four age ranges (≤20 
years, 21 to 40, 41 to 60, and >60 years). Of 697 subjects, 
29 (4.2%) were aged 20 years or less; 297 (42.6%) were 
aged between 21 and 40 years; 275 (39.4%) were aged 
between 41 and 60 years, and 96 (13.8%) were aged over 
60 years (Chart 1).
Graph 1. Distribution by age range, All individuals (N=697)
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In the CRF group, 8 patients (2.3%) were aged 20 
years or less; 118 (34.6%) were aged between 21 an 40 
years; 150 (43%) were aged between 41 and 60 years; and 
65 (19.1%) were aged over 60 years (Chart 2). The mean 
age in this group was 46.5 years (SD ± 14.84), ranging 
from 16 to 88 years.
clerosis; among 179 control group subjects in the same age 
bracket, 12 (6.7%) presented myringosclerosis (p = 0.39). 
In the 41 to 60 years bracket, myringosclerosis was found 
in 16 (10.7%) of 150 group A patients, and in six (4.8%) 
of 125 group B subjects (p = 0.11).
Graph 2. Distribution by age range, Group A (N = 341)
In the control group, 21 subjects (5.9%) were aged 
20 years or less; 179 (50.3%) were aged between 21 an 40 
years; 125 (35.1%) were aged between 41 and 60 years; 
and 31 subjects (8.7%) were aged over 60 years (Chart 3). 
The mean age in this group was 39.9 years (SD ± 14.39), 
ranging from 10 to 82 years.
Graph 3. Distribution by age range, Group B (N = 356)
Looking at the most prevalent age groups (21 to 
40 years, and 41 to 60 years), the following results are 
seen (Tables 6 and 7): among 188 group A patients aged 
between 21 and 40 years, 12 (10.1%) presented myringos-
Table 6. Frequency of myringosclerosis in group A and B subjects 
aged between 21 and 40 years.
 myringosclerosis  no myringosclerosis TOTAL
n% n% n%
GROUP A 12 10,1 106 89,9 118 100
GROUP B 12 6,7 167 93,3 179 100
PR  = 1,29 CI = 0,84 -1,97x2 = 0,73 p = 0,39
Table 7. Frequency of myringosclerosis in group A and B subjects 
aged between 41 and 60 years.
 myringosclerosis no myringosclerosis TOTAL
n% n% n%
GROUP A 16 10,7 134 89,3 150 100
GROUP B 6 4,8 119 95,2 125 100
PR  = 1,37 CI = 1,04 -1,82x2 = 2,44 p = 0,11
 
Myringosclerosis and duration of dialysis
In the full sample (with and with no myringoscle-
rosis), 50.4% had been on dialysis for less than 2 years, 
25.3% had been on dialysis for between 2 and 5 years, and 
24.3% had been on dialysis for over 5 years.
Among CRF patients with otoscopically diagnosed 
myringosclerosis, 16 (40%) had been on dialysis for less 
than 2 years, 12 (30%) had been on dialysis for between 
2 and 5 years, and 12 (30%) had been on dialysis for over 
5 years. Among CRF patients with no myringosclerosis, 
156 (42.4%) had been on dialysis for less than 2 years, 74 
(24.6%) had been on dialysis for between 2 and 5 years, 
and 71 (23.6%) had been on dialysis for over 5 years (x2 
= 1.99; p = 0.37). These numbers are shown on Charts 
4 and 5.
Myringosclerosis and serum calcium
Serum calcium was measured in 208 of 341 group 
A patients. Of these, hypocalcemia was present in four 
patients (2%), normal calcium levels were normal in 96 
patients (46%), and hypercalcemia was present in 108 
patients (52%).
Table 8 shows that only one of four hypercalcemic 
patients presented myringosclerosis. Otoscopy revealed 
a myringosclerotic plaque in 11 (11.5%) of 96 normal 
calcium level patients; the remaining 85 (88.5%) of these 
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Myringosclerosis and serum phosphorous
Serum phosphorus was measured in 206 group A 
patients. Low phosphorus levels were found in 16 (7.8%) 
of these patients, while 68 patients (33%) had normal 
phosphorus levels, and 122 patients (59.2%) presented 
elevated phosphorus levels.
Table 9 shows the frequency of myringosclerosis 
in each subgroup (low phosphorus levels: 12.5% with 
myringosclerosis; normal phosphorus levels: 13.2% with 
myringosclerosis; elevated phosphorus levels: 12.3% with 
myringosclerosis), x2 = 0.04 and p = 0.982.
The mean phosphorus level was 5.92mg/dl; the 
minimum level was 2.20mg/dl and the maximum level 
was 62.0mg/dl (SD ± 5.26mg/dl).
 
Myringosclerosis and serum PTH
Serum PTH was measured in 158 CRF patients, of 
which 46 (29%) had below normal PTH, 44 (28%) had nor-
mal serum PTH, and 68 (43%) had elevated serum PTH.
Myringosclerotic plaques were found in 5 (10.8%) 
of 46 low-PTH patients, in 10 (22.7%) of 44 normal PTH 
patients and in 8 (11.7%) of 68 elevated PTH patients (x2 = 
3.29; p = 0.192); these results are presented in Table 10.
The mean serum PTH level was 285.3pg/ml. Values 
ranged from 1pg/ml to 1,923pg/ml (SD ± 380.65pg/ml).
Graph 4. Distribution by time of dialysis, Group A c/ MS (N = 40)
Dialysis time (in years)
Graph 5. Distribution by time of dialysis, Group A s/ MS (N = 301)
Table 8. Frequency of myringosclerosis in group A patients presen-
ting low, normal and elevated serum calcium levels.
 Hypocalcemia 
Normocalce-
mia  
Hypercalce-
mia  
n% n% n%
myringosclerosis  1 25  11 11,5 14 8,4
no 
myringosclerosis 
 3 75  85 88,5 94 91,6
TOTAL  4 100  96 100  108 100
x2 = 0,69 p = 0,70
Table 9. Frequency of myringosclerosis in group A patients presen-
ting low, normal and elevated serum phosphorus levels.
 
Hipophospha-
temia
Normophos-
phatemia
Hyperphos-
phatemia
n% n% n%
myringosclerosis  2 12,5  9 13,2 15 12,3
no 
myringosclerosis 
 14 87,5  59 86,8  107 87,7
TOTAL  16 100  68 100  122 100
x2 = 0,04 p = 0,982
96 patients had no myringosclerosis. Myringosclerosis 
was found in 14 (13%) of 108 hypercalcemic patients, and 
the remaining 94 (87%) of these 108 patients had normal 
tympanic membranes (x2 = 0.69; p = 0.70).
The lowest calcium level in these patients was 
4.2mg/dl and the highest calcium level was 108.0mg/dl 
(SD ±12.84mg/dl).
 
Table 10. Frequency of myringosclerosis in group A patients presen-
ting low, normal and elevated PTH.
 Low pth Normal pth Elevated pth
n% n% n%
myringosclerosis  5 10,8  10 22,7  8 11,7
no 
myringosclerosis 
 41 89,2  34 77,3  60 88,3
TOTAL  46 100  44 100  68 100
x2: = 3,29 p = 0,192 
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DISCUSSION
Tympanosclerosis is the end stage of a process that 
starts as acute or chronic inflammation of the middle ear 
lamina propria.14 Many authors have described the pa-
thology that leads to tympanosclerosis; this process begins 
with excessive collagen production in the lamina propria 
of the middle ear mucosa, followed by hyalinization, cal-
cification and bone or cartilage metaplasia.1,5,11,15,16
The etiology and pathogeny, and the reasons why 
only some patients develop this type of process, are not 
fully understood. A few studies have attempted to establish 
an etiological and pathogenic association with certain 
factors; the papers published by Schiff et al.,17 and Schiff 
& Yoo,18 describe a relation between tympanosclerosis 
and the autoimmune reaction, and by Koç & Uneri,19 
have raised the hypothesis that there might be a genetic 
predisposition.
The tympanosclerotic plaque calcification process 
is similar to other types of pathological calcification. Ec-
topic calcification has long been studied both structurally 
and ultra-structurally. There are basically two methods 
for depositing calcium crystals in tissues other than bone, 
namely metastatic and dystrophic calcification. Metastatic 
calcification occurs passively by serum calcium phosphate 
crystal precipitation in patients with certain diseases in 
which serum levels of these crystals is elevated.20 This 
type of calcification appears to depend on hypercalcemia 
and hyperphosphatemia, which have an essential role in 
the process.21 Dystrophic calcification involve a complex 
active cell mechanism that has been widely researched 
without much success. It is seen as calcification of arte-
ries and viscera in chronic renal disease.20 Certain authors 
have questioned the role of elevated serum calcium 
and phosphorus in the pathophysiology of this type of 
calcification,20 although various papers have associated 
these two conditions.22-24
An altered glomerular filtration rate due to kidney 
disease leads to phosphate retention in the serum. Ex-
cess serum phosphorus tends to bind to free calcium to 
form precipitates that may originate ectopic calcification. 
Precipitation in turn reduces serum calcium levels, which 
stimulates the parathyroid glands to produce PTH; this 
hormone acts on bone metabolism, and may demineralize 
bone; the minerals that are released reach the bloodstream 
and may initiate new calcification.20,25,26 There seems to be 
a failure in calcium and parathyroid feedback mechanisms, 
so that this type of dysmetabolism is perpetuated. In this 
situation, PTH secretion is not adequately inhibited; serum 
PTH levels may actually be elevated due to decreased 
calcitriol levels.25 
It seems almost certain that calcium and phosphorus 
dysmetabolism, which is present in chronic renal disease 
due to the condition itself or due to dialysis, is the basis 
of ectopic calcification, particularly in the cardiovascular 
system and viscera. Rather than a single mechanism, it 
appears that there are various etiologic and pathogenic 
causes underlying different types of calcification, which 
explains the biochemical variations that are found in these 
patients.
Matrix vesicles were described in 1969 as essen-
tial components of pathological calcification in various 
tissues.12,13 These vesicles are found within the collagen 
matrix in connective tissue; electron microscopy has reve-
aled its mineral content. Such vesicles originate from the 
cell membrane of cells that have undergone apoptosis, and 
diffuse into the collagen matrix; they eventually coalesce 
and form a calcium phosphate plaque.12,13,22 This process 
has been demonstrated in atheromatous plaques in CRF 
patients; there is strong evidence suggesting that hypercal-
cemia and hyperphosphatemia participate in the origin of 
these vesicles.22,27 Matrix vesicles also participate in other 
types of calcification, including tympanosclerosis.4 
Other cellular and hormonal elements have been 
found to participate actively in tympanosclerotic calcifica-
tion and in the calcification of other tissues. Macrophages, 
for instance, may become osteoclasts and produce osteoac-
tive proteins.6,7,11 Alkaline phosphatase28 and osteopontine, 
a bone matrix protein found in various calcified tissues,7-10 
may also participate in this process. It is clear that there are 
significant similarities between tympanosclerotic calcifica-
tion and that which involves other tissues in CRF patients 
or those with other systemic diseases.
Such similarities have led to the hypothesis that 
tympanosclerosis, which is initiated by local inflammation 
following trauma or acute and chronic infection of the 
middle ear mucous membrane, might arise regardless of 
any association with other diseases. On the other hand 
tympanosclerosis could be influenced by the typical dys-
metabolism of CRF patients, in which the prevalence of 
tympanosclerosis would be increased.
Groups A and B were similar relative to the history 
of otitis and skin color, but differed in relation to age 
and sex.
Table 2 shows data suggesting that there was a sta-
tistically significant difference between the occurrence of 
myringosclerosis in CRF patients and in the control group 
(11.7% versus 5.1%). Group A patients had a 1.46 higher 
risk of developing myringosclerosis compared to healthy 
subjects. These numbers demonstrate a clear association 
between CRF and myringosclerosis, and may also be used 
to roughly estimate the prevalence of myringosclerosis in 
our population (5.1%), a datum that is not found in the 
literature we surveyed.
Table 2 reveals that both groups were similar relative 
to their history of otitis; this variable, therefore, does not 
affect the results shown on Table 1. Still, to exclude any 
possibility that this influence might be present, cases with 
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no history of otitis in both groups were also analyzed. Al-
though the samples were reduced by using this exclusion 
criterion, it became clear that the statistical significance 
relative to the occurrence of myringosclerosis was further 
increased in favor of group A (12.3% versus 4.7%), whe-
re the risk was 1.53 higher. A memory bias should also 
be taken into account, as many of these patients were 
elderly persons, and might not have remembered their 
clinical past precisely; this bias, however, was present in 
both groups.
There are no published papers that unequivocally 
attribute an increased predisposition for tympanosclerosis 
to one sex over the other. Some papers that have reported 
sex prevalence have shown that there is no sex-specific 
difference;2,29,30 two papers found a higher prevalence in 
males.31,32 These two studies, however, admit that the incre-
ased male prevalence was due to the well-known higher 
incidence of middle ear inflammatory disease in men.
The sample groups in this study were different re-
lative to sex (p < 0,001); there were many more females 
in group B. This might be explained by the fact that care-
takers of the otorhinolaryngology outpatient and infirmary 
patients formed this group; these persons are socially and 
economically similar to the patients enrolled in the study, 
but are mostly female. An analysis of the occurrence of 
myringosclerosis and sex in groups A and B) reveals that, 
although there is no statistically significant difference (p 
= 0.94), females predominated among myringosclerosis 
subjects (60.3% against 39.7%). If this trend were to be 
confirmed, a higher occurrence of myringosclerosis would 
be expected in group B, which contained many more 
women. Table 1, however, shows that the opposite was 
found, strengthening the hypothesis that CRF is a predis-
posing factor for middle ear calcification.
There was a statistically relevant difference betwe-
en both groups relative to skin color. We do not believe, 
however, that this difference would have influenced the 
results of our comparison of the occurrence of myringos-
clerosis between groups A and B; there have been no 
reports indicating any statistically relevant difference in 
the prevalence of tympanosclerosis between races. A com-
parison of the frequency of myringosclerosis between the 
three main age groups revealed no significant difference, 
excluding the possibility that the former variable would 
have altered the results.
The age distribution was different between both 
groups. There is a controversy in the literature about 
whether any age range would show a higher prevalence 
of tympanosclerosis. Some authors have stated that this 
condition has a higher prevalence in children, since they 
are subject to frequent otitis media and surgery for placing 
ventilation tubes. Other believe that, as tympanosclerosis 
is an irreversible chronic process, it would be more pre-
valent in an older age range.29,32 Møller,10 however, has 
demonstrated that this process may be reverted.
There appears to be an age-related bimodal curve 
in the prevalence of tympanosclerosis; a first peak occurs 
in children, who are at risk for otitis and ventilation tube 
surgery. A second peak occurs after age 40 years, when 
the progressive and irreversible nature of adult tympanos-
clerosis speaks louder. A lower prevalence zone between 
these two peaks might be explained by the spontaneous 
regression of this condition that is observed in children. 
Our sample does not allow an adequate assessment of this 
age group, since it did not include children or teenagers. 
The adults in our sample (groups A and B) had a higher 
occurrence in an intermediate age range (Charts 1, 2 and 
3), between ages 21 and 40, and 41 and 60 years. There 
is, however, a frequency inversion in these two are ranges 
between both groups, where subjects aged over 40 years 
predominated in group A (Tables 2 and 3). This finding 
might have influenced the final result, although the paper 
we reviewed did not reach a consensus about the relation 
between tympanosclerosis and age. An evaluation of the 
occurrence of myringosclerosis in each of those two age 
ranges (Tables 4 and 5) reveals that the difference we 
found was smaller than the difference found in the global 
analysis (PR = 1.29 and p = 0.39 for ages 21 to 40 years, 
and PR = 1.37 and p = 0.11 for ages 41 to 60 years), which 
was, however, not statistically significant. We cannot state 
with certainty whether CRF contributed to the onset of 
myringosclerosis in our sample, although we repeatedly 
found a trend indicating a higher occurrence of myringos-
clerosis in CRF patients. It should be borne in mind that 
ageing tends to coincide with the presence and severity 
of renal disease; these become confounding variables in 
this type of study. Possibly an age-paired control group 
would clarify this matter.
There was no significant difference between group 
A subjects with and with no myringosclerosis relative to 
the duration of dialysis (p = 0.37). Kabaya et al.33 were 
also unable to find any influence from the duration of 
dialysis on the incidence of vascular calcification in hemo-
dialyzed patients. Leskinen et al.34 also found no significant 
difference in carotid calcification in CRF patients before 
or after dialysis. Although various authors contend that 
metabolic changes induced by dialysis might operate on 
the etiology and pathogeny of ectopic calcification in CRF 
patients, there is no consensus in the literature on this sub-
ject. Our results suggest that the duration of hemodialysis 
does not appear to have a significant role in the onset of 
tympanosclerosis, event though this condition is possibly 
influenced by renal disease.
Serum calcium and phosphorus, measured in part 
of the CRF patient sample, were not different between 
patients with positive or negative otoscopies. Low or ele-
vated calcium or phosphorus levels in these patients did 
not change the occurrence of myringosclerosis (p = 0.70 
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and p = 0.982) as shown on Tables 6 and 7. Table 8 shows 
that there was a higher occurrence of myringosclerosis in 
patients with normal serum PTH levels (22.7% compared to 
10.8% in low serum PTH and 11.7% in elevated serum PTH 
levels); this finding, however, was not statistically signifi-
cant (p = 0.192). At first sight, if there were a cause-effect 
relation between CRF and tympanosclerosis, the etiological 
and pathogenic mechanism of this condition would be 
similar to that found in vascular and visceral calcification, 
as Alfrey20 has reported. Serum calcium, phosphorus and 
PTH, however, were measured only once in this trial upon 
inclusion of patients; these measurement, therefore, are 
a picture of the metabolic situation at a given moment, 
rather than a well-established dysmetabolic pattern in these 
patients. Their calcium, phosphorus and PTH levels may 
vary significantly according to the progression of kidney 
failure, to dialysis and to other associated conditions such 
as diabetes, the diet and others.
The variables we studied suggest that CRF does 
have a significant influence on the onset of tympanoscle-
rosis. The mechanism whereby renal disease generates 
tympanic sclerosis, however, is not clear from the data in 
this study, as the metabolic changes we studied and the 
duration of hemodialysis appeared to have no influence 
on the frequency of myringosclerosis. The literature states 
that the effects of altered calcium, phosphorus and PTH 
levels on pathological calcification may take place without 
any serum elevation of these factors being detected. It 
has been well defined that ultra-structural changes in 
tympanosclerosis are similar to those found in vascular 
and visceral calcification in CRF patients. Furthermore, as 
the serum metabolic changes in these patients are present 
systemically, it is logical to infer that their effect on the 
calcification process takes place similarly in the lamina pro-
pria of the middle ear mucosa. This is even more evident 
in the group of patients that presented myringosclerosis 
without an otological history of inflammation, where the 
only clear cause was renal disease, notwithstanding the 
aforementioned memory bias that might have affected 
these results to some uncertain degree.
Finally, if we look only at the control group, it 
could be stated that the prevalence of tympanosclerosis 
in persons aged over 20 years is 5%. It is possible that 
this percentage might have been even higher if we had 
included subjects aged 0 to 20 years; this, however, was 
not the aim of this study.
CONCLUSION
There was no influence of serum levels of calcium, 
phosphorus or the PTH on the occurrence of myringos-
clerosis in the study group.
There was no influence of the duration of hemo-
dialysis on the occurrence of myringosclerosis in the study 
group.
There was a statistically significant difference be-
tween the CRF patient group and the control group in the 
frequency of myringosclerosis.
These data, however, cannot confirm with certainty 
that CRF had any relation with the increased occurrence 
of myringosclerosis, as the variable age might have in-
fluenced the results.
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